Keyphrases
Hepatitis C Virus
84%
Home Parenteral nutrition
78%
Crohn's Disease
70%
Chronic Intestinal Failure
60%
Hepatitis C
56%
Intestinal Failure
44%
Risk Factors
44%
Cirrhosis
41%
Small Intestine
40%
Hepatocellular Carcinoma
33%
Protease Inhibitors
33%
Motility
32%
Video Capsule Endoscopy
31%
Duodenal-jejunal Bypass Liner
28%
Failure Management
28%
Host Factors
28%
Nonagenarians
28%
Intravenous Supplementation
28%
Recurrent Disease
28%
Patient Understanding
28%
Strong Opioids
28%
Antidepressant Use
28%
Older Patients
28%
Response to Therapy
28%
Disease Development
28%
Ribavirin
28%
Patient Assessment
28%
Patient-reported Outcomes
28%
Paritaprevir
28%
Ombitasvir
28%
Ritonavir
28%
Dasabuvir
28%
Optical Coherence Tomography Angiography (OCT-A)
28%
Viral Factors
28%
Host Response
28%
R353Q
28%
Critical Flicker Frequency
28%
Inflammatory Bowel Disease
28%
Plasma Vitamin C
28%
Multicenter Trial
28%
Diagnostic Performance
28%
Aged 80 Years and over
28%
National Reference Center
28%
Cognitive Impairment
28%
Endoscopic Ultrasound
28%
Old Age
28%
Endoscopic Retrograde Cholangiopancreatography
28%
Bacteremia
28%
Emergency Department
28%
Diabetic Patients
28%
Medicine and Dentistry
Intestinal Failure
100%
Home Parenteral Nutrition
76%
Hepatitis C Virus
56%
Crohn's Disease
51%
Liver Cirrhosis
41%
Diagnosis
39%
Capsule Endoscopy
33%
Hepatocellular Carcinoma
33%
Hepatitis C
33%
Liver Disease
33%
Cohort Analysis
31%
Recurrent Disease
30%
Patient with Crohn's Disease
30%
Patient with Obesity
28%
Opiate
28%
Diabetes Mellitus
28%
Bacteremia
28%
Ribavirin
28%
Endoscopic Ultrasound
28%
Ascorbic Acid
28%
Endoscopic Retrograde Cholangiopancreatography
28%
Ombitasvir
28%
Paritaprevir
28%
Ritonavir
28%
Dasabuvir
28%
Proteinase Inhibitor
28%
Glycemic Control
28%
Emergency Department
28%
Gene Linkage
28%
Antidepressant
28%
Ingestion
28%
Disease
28%
Supplementation
26%
Adverse Event
23%
Gut
18%
Body Mass Index
18%
Odds Ratio
16%
Catheter Infection
16%
Chronic Liver Disease
15%
Prevalence
15%
Side Effect
14%
Hepatitis C Virus Genotype 1
14%
Bleeding
14%
Cancer
13%
Nonalcoholic Fatty Liver
12%
Liver Transplantation
12%
Antiviral Therapy
11%
Logistic Regression Analysis
11%
Patient Referral
10%
Nutrient Absorption
9%
Pharmacology, Toxicology and Pharmaceutical Science
Intestinal Failure
99%
Hepatitis C Virus
84%
Crohn's Disease
61%
Hepatitis C
61%
Adverse Event
42%
Liver Cirrhosis
36%
Proteinase Inhibitor
33%
Liver Cell Carcinoma
33%
Side Effect
33%
Recurrent Disease
30%
Host Factor
28%
Diabetes Mellitus
28%
Antibiotic Prophylaxis
28%
Ascorbic Acid
28%
Ritonavir
28%
Ombitasvir
28%
Paritaprevir
28%
Dasabuvir
28%
Bacteremia
28%
Ribavirin
28%
Cognitive Defect
28%
Opiate
28%
Remission
28%
Disease
28%
Prevalence
25%
Antibiotics
21%
Catheter Infection
16%
Chronic Liver Disease
15%
Retinol
14%
Alpha Tocopherol
14%
Tree
14%
Vitamin D
14%
Hepatitis C Virus Genotype 1
14%
Antiviral Therapy
13%
Nonalcoholic Fatty Liver
12%
Neurotoxicity
11%
Hepatic Encephalopathy
11%
Peginterferon
9%
Trace Element
9%
Antivirus Agent
8%
Fibrosis
8%
Viral Clearance
7%
Retrospective Study
7%
Chronic Hepatitis C
5%
Combination Therapy
5%
Infection Rate
5%
Virus Carrier
5%
Disease Duration
5%
Bisacodyl
5%
Neoplasm
5%